Recovery & Repair · Blend · research compounds
BPC-157 + TB-500
Recovery blend · 5 mg + 5 mg · Recovery
The classic recovery pairing at the starting strength.
- Form
- 10 mg — pre-reconstituted in the Cellvéra injector
- Oversight
- Licensed clinician, included
- Price
- From R3 978 / protocol
For research purposes only · Not for human consumption
Begin your intakeOpens a private email to our concierge · nothing is charged
Checkout begins your confidential medical intake. BPC-157 + TB-500 is dispensed only if a licensed clinician prescribes it after reviewing your intake — nothing is charged until your provider approves.
Pathway
BPC-157 and TB-500 combined in a single preparation at 5 mg each — the most popular recovery pairing in circulation, at its entry strength.
Mechanism
Complementary mechanisms: BPC-157 is associated with new blood-vessel formation and local healing signals, while TB-500 governs the actin machinery that lets repair cells migrate into damaged tissue.
Studied for
- Soft-tissue injury recovery — tendon, ligament, muscle
- Reduced inflammation during rehabilitation
Areas of research interest — not promised outcomes.
Where the evidence stands
No trial has tested the combination in humans. The rationale is mechanistic reasoning, not evidence of a synergistic effect.
Typical protocol
Dosing is individualised and set by your supervising clinician at intake. Published human dosing for this compound is not established; conservative titration and monitoring are part of every protocol.
Contraindications & cautions
Combines two compounds that are not approved for human use. Both prohibited in competitive sport (WADA). Active malignancy or cancer history. Pregnancy or breastfeeding.
Prescribed only after evaluation by your supervising provider, based on your history and bloodwork.